Regulation
FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings
Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over regulating AI.
Every story of October 2026, newest first. How AI is changing drug discovery, clinical trials, manufacturing and regulation.
Regulation
Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over regulating AI.
Industry
AIIA-iCAINE launches an IPR facility, signs two MoUs with the World Ayurveda Foundation and Reliance Retail, and conducts a workshop on entrepreneurship and design thinking.
Drug Discovery
The six-day programme, organised by FABA with academic and industry partners, covers medicinal chemistry, AI-based drug design, biologics and emerging therapeutic modalities
Industry
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination.
Deals
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos, and drug development from BMS.
Deals
Dr Supriya Shidaye, Principal, Vivekanand Education Society’s College of Pharmacy, discusses how AI, automation and digital technologies are reshaping pharmacy education, while closer industry-academia collaboration can…
Deals
In this edition of STAT’s AI Prognosis: What does Isomorphic Labs’ high valuation say about AI’s role in drug development, and the debate around AI and cost of care.
Industry
As generative AI moves toward performing increasingly consequential clinical functions, the American Medical Association (AMA) is urging the U.S. Food and Drug Administration to address a foundational question: Who is…
Clinical Trials
OpenAI is acquiring startup Orchestra Bio and plans to merge it with its life sciences AI platform Rosalind. The goal is to build AI agents that help pharma teams coordinate drug development, from tracking trials to…
Regulation
Rick Abramson, a radiologist by training and the director of FDA’s Digital Health Center of Excellence said, “We ended up putting out this idea that maybe these devices are starting to behave a little bit more like me…
Deals
OpenAI says it’s adding Orchestra’s team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments…
Deals
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Industry
Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage.
Drug Discovery
Iambic Therapeutics, an AI-enabled biotech company, will apply the IPO proceeds toward clinical development of its pipeline of internally discovered and wholly owned cancer drugs. Iambic also has R&D alliances with…
Regulation
Three former FDA chiefs lit into the Trump administration, criticizing the now former FDA officials who oversaw a massive staff exodus
Industry
Dr Ashok Patel, Aesthetic Surgeon, Founder and Chief Medical Officer, Brilliance Cosmocare, explains how AI is shaping skin analysis, cosmetic treatment planning, hair restoration and patient consultations, while…
Regulation
Lobbying groups for doctors and hospitals and trade groups are working behind the scenes on how to regulate AI in medicine.
Regulation
The VIGOR programme will advance four drug candidates from TRL-4 to TRL-6 over three years, covering preclinical development and preparation for clinical trials
Regulation
In this edition of STAT’s AIP Prognosis: Unresolved regulatory questions around Utah’s AI sandbox, and more health AI news.
Regulation
In this edition of STAT Health Tech: New AI guidances expected from the the FDA in 2027, Utah expanding its AI sandbox, and more.
Industry
Utah plans to allow an AI product to evaluate patients and write new drug prescriptions without prior human review.
Regulation
Dr Rajiv Desai, Senior Technical Advisor, Quality and Regulatory, IPA, highlights what pharma manufacturers need to get right when deploying AI at scale, from data and validation to quality, workforce readiness and…
Industry
“Are we entering a world in which some (or all) Nobels will be awarded to Claude, ChatGPT, or their AI successors, rather than human scientists?” asks Jeffrey Flier.
No stories match these filters.
Subscribe on YouTube, or get an email the day each new lesson goes live.
Ask ai2hired
Answers from this site only, with the pages they come from.
Hi! I can help with the free course: lessons, seasons, career paths, workbooks, credentials, the free tools and your account.
AI answers can be wrong: check the linked page. Not stored. Need a person? info@ai2hired.org